Cerchione C, Alassi N, Cangini D, Tassinari S, Spedaluzzi A, Azzali I, Cortesi S, Feliciani G, Rossi A, Ronconi S, Ceccolini M, Tonelli M, Musuraca G, Normanno N, Scarpi E, Simonetti G, Martinelli G, Richardson PG, Marchesini M. Shared high-risk transcriptional programs across multiple myeloma stages associate with disease progression and poor outcome. Haematologica [Internet]. 2026Nov.12 [cited 2026Nov.14];. Available from: https://haematologica.org/article/view/14538